J&J falls short in a Remicade patent case as star drug slips in Q4
J&J falls short in a Remicade patent case as star drug slips in Q4 FiercePharma Johnson & Johnson loses Remicade patent on appeal Minnesota Lawyer J&J Posts Loss on Tax Charge; Patent Ruling Stings — WSJ Fox Business Full coverage